Understanding Patient Perspectives on Research Participation

Biobanking in sickle cell disease is an essential tool for advancing genomic research and personalized therapies. Recent data published in Genetics in Medicine explores the diverse preferences of adolescents and parents regarding sample storage and data sharing. Understanding these nuances is vital for clinicians to foster trust and ensure ethical participation in research.

The study analyzed responses from 200 caregivers and 100 adolescents. Interestingly, adolescents showed a higher willingness to permit long-term sample storage compared to their parents. Specifically, 82% of adolescents approved of long-term storage, while only 69% of parents felt the same. This discrepancy suggests that younger patients might view the future benefits of genetic research with more optimism than their caregivers. Furthermore, both groups broadly supported using samples for research beyond sickle cell disease (SCD).

However, support for data sharing outside the home institution remains limited. Only about 58% of both groups agreed to share samples with external researchers, even with privacy protections. This caution stems largely from mistrust, which was a dominant theme for 62% of participants. Consequently, researchers must prioritize transparency and robust privacy measures to address these concerns. Moreover, the study found that altruism remains a powerful motivator, driving 78% of the participants to consider biobanking.

Addressing Trust in Biobanking in Sickle Cell Disease

In India, where SCD is highly prevalent, applying these insights is critical. The Indian Council of Medical Research (ICMR) emphasizes that biobanking should respect individual autonomy through clear informed consent. Therefore, offering flexible consent options—ranging from specific to broad consent—could accommodate the diverse views of the patient population. By emphasizing how biobanking helps future generations, clinicians can strengthen the patient-provider partnership and mitigate concerns regarding sample ownership and privacy.

Frequently Asked Questions

What is the difference between specific and broad consent in biobanking?

Specific consent limits sample use to a particular study. In contrast, broad consent allows researchers to use samples for future, often unspecified, medical research projects under ethical oversight.

Why do adolescents show higher interest in long-term sample storage?

Adolescents often express higher altruism and a stronger desire to contribute to future medical breakthroughs. Additionally, they may feel more comfortable with technological and genetic advancements than older generations.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional physician-patient relationship. Refer to the latest local and national guidelines for clinical practice.

References

1. Weaver MS et al. Beyond Mistrust: Diverse Biobanking Preferences Among Parents and Adolescents with Sickle Cell Disease. Genet Med. 2026 Jun 19. doi: undefined. PMID: 42318776.

2. Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. 2017.

3. Beskow LM et al. Towards Best Practices for Biobanking: Informed Consent as an Ongoing Process. Stanford Journal of Law, Science, & Policy. 2009.